Approval · Notice of Compliance 22833 · 2019
FUCITHALMIC: Notice of Compliance 22833
Issued October 29, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22833
- Date
- October 29, 2019
- Company
- Amdipharm LimitedNorthwood, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To update the Product Monograph (PM) with Level III and format changes, and to update the labels to align with Plain Language Labelling (PLL) Guidelines.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUCITHALMIC | Not yet assigned | — |
Medicinal ingredients
- FUSIDIC ACID 1 PER